IOVA
USDIovance Biotherapeutics Inc. Common Stock
$2.300+0.050 (2.222%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.250
High
$2.380
Low
$2.080
Volume
17.39M
Company Fundamentals
Market Cap
913.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
13.73M
Exchange
NGM
Currency
USD
52-Week Range
Low $1.64Current $2.300High $10.86
Related News
GlobeNewswire
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
26% Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow Up Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of 2027 SAN CARLOS, Calif., Nov. 03, 2025
View more
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $9
HC Wainwright & Co. analyst Joseph Pantginis maintains Iovance Biotherapeutics with a Buy and lowers the price target from $20 to $9.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.